| Name | Visionworks Inc |
|---|---|
| Organization Name | Visionworks Inc |
| Location | 4550 E Cactus Rd, Ste 30, Phoenix, Arizona 85032 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (602) 494-0929 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers in Ireland and the United States identified the genetic make-up (genotype) of 395 individuals born with neural tube defects (spina bifida or encephalocele) and 848 controls.
Advanced practice providers (APPs) have lower productivity compared with emergency department physicians, seeing fewer and less complex patients and generating less relative value units per hour, and having no apparent impact on patient satisfaction and safety metrics.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
The force gravity and physical activity put on our bones causes tiny tears in the membranes of the tiny cells that enable us to make or break down bone, scientists say.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 1 days ago
| NPI Number | 1154574408 |
| Organization Name | VISIONWORKS, INC |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 4575 E Cactus Rd Ste 100a, Phoenix, AZ 85032 |
| Phone Number | 602-494-0929 |
News Archive
Researchers in Ireland and the United States identified the genetic make-up (genotype) of 395 individuals born with neural tube defects (spina bifida or encephalocele) and 848 controls.
Advanced practice providers (APPs) have lower productivity compared with emergency department physicians, seeing fewer and less complex patients and generating less relative value units per hour, and having no apparent impact on patient satisfaction and safety metrics.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
The force gravity and physical activity put on our bones causes tiny tears in the membranes of the tiny cells that enable us to make or break down bone, scientists say.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 1 days ago
| NPI Number | 1265524185 |
| Organization Name | TOM SOWASH O.D. & ASSOCIATES, P.C. |
| Doing Business As | EYEMASTERS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 4550 E Cactus Rd, Suite 30, Phoenix, AZ 85032 |
| Phone Number | 602-494-0929 |
News Archive
Researchers in Ireland and the United States identified the genetic make-up (genotype) of 395 individuals born with neural tube defects (spina bifida or encephalocele) and 848 controls.
Advanced practice providers (APPs) have lower productivity compared with emergency department physicians, seeing fewer and less complex patients and generating less relative value units per hour, and having no apparent impact on patient satisfaction and safety metrics.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
The force gravity and physical activity put on our bones causes tiny tears in the membranes of the tiny cells that enable us to make or break down bone, scientists say.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 1 days ago
News Archive
Researchers in Ireland and the United States identified the genetic make-up (genotype) of 395 individuals born with neural tube defects (spina bifida or encephalocele) and 848 controls.
Advanced practice providers (APPs) have lower productivity compared with emergency department physicians, seeing fewer and less complex patients and generating less relative value units per hour, and having no apparent impact on patient satisfaction and safety metrics.
Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
The force gravity and physical activity put on our bones causes tiny tears in the membranes of the tiny cells that enable us to make or break down bone, scientists say.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 1 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |